Mar 28 |
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
|
Mar 13 |
FibroBiologics to Present at Advanced Wound Care Summit USA
|
Mar 6 |
FibroBiologics Appoints Ruben A. Garcia as General Counsel
|
Feb 29 |
FibroBiologics Files 2023 Form 10-K Annual Report
|
Feb 20 |
FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum
|
Feb 13 |
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
|
Feb 8 |
FibroBiologics Announces Three United States Patents for Fibroblast Technology
|
Feb 6 |
FibroBiologics Announces Three Japanese Patents on Fibroblast Technology
|
Feb 1 |
FibroBiologics stock tumbles 20% during second day of trading
|
Feb 1 |
FibroBiologics goes public through direct listing on Nasdaq
|